Insights from BCC Research

Google Spin-Off Jumps Into the Wearable Device Game

Posted by Laurie L. Sullivan on Dec 28, 2017 11:45:00 AM

Smartwatch.jpg

Earlier this month, BCC Research hosted an event “Connected Medical Devices: Bridging the Gap Between Wearables and Clinical Applications” in Boston, MA. BCC Research Senior editors Michael Sullivan and Robert G. Hunter discussed the future of wearable medical devices, especially those that link clinical and consumer applications. In her blog post from August 2017, Laurie Sullivan writes about one Google spin-off coming ever closer to “bridging the gap.”

Read More

Topics: Life Sciences, Healthcare

Can Getting A “Young” Blood Transfusion Turn Back Time?

Posted by Laurie L. Sullivan on Nov 8, 2017 10:00:00 AM

Blood Transfusion.jpegConditions such as immunodeficiency and bleeding disorders are powerful growth factors of the blood plasma industry. In a recent analysis, BCC Research found that the rising demand for immunoglobulins (more commonly known as antibodies), an integral part of the immune response, is the main driver of the global market for blood plasma products. Product launches and improvements in existing technologies are expected to expand this market from approximately $16.8 billion in 2016 to $23.0 billion by 2021.

Read More

Topics: Life Sciences, Healthcare

Function Follows Form: Trendy Tattoos Are a Cover-up for Vital Work

Posted by Laurie L. Sullivan on Oct 31, 2017 2:30:00 PM

diabetes-blood-sugar-diabetic-medicine-46173.jpegThe use of disposable medical sensors is continuously increasing, fueling a multibillion-dollar global industry. BCC Research predicts that this market will expand at a healthy double-digit growth rate worldwide, with the potential to reach $9 billion by 2022. An increase in geriatric populations all over the world will lead to more demand for continuous health monitoring devices for a larger number of diseases pertaining to cardiovascular, audiology and urology systems.

Read More

Topics: Life Sciences, Healthcare

Biomarker Advances Push Rapid Growth in Biologic Imaging Reagents

Posted by Laurie L. Sullivan on Oct 20, 2017 12:15:00 PM

Biologic imaging reagents play a fundamental role in today’s medical, pharmaceutical and biotechnology industries. Such reagents are integral to the diagnostics industry, which is the largest market for these products. Driven primarily by advancements in biomarker technology in medical diagnostics, the global market for biologic imaging reagents has the potential to reach $23.9 billion by 2022. In a new study by BCC Research, the industry’s prospects are examined by the main reagent classes: contrast, nuclear (radioactive) and optical.

Read More

Topics: Life Sciences, Healthcare